Cargando…
Efficacy of carbapenem vs non carbapenem β-lactam therapy as empiric antimicrobial therapy in patients with extended-spectrum β-lactamase-producing Enterobacterales urinary septic shock: a propensity-weighted multicenter cohort study
BACKGROUND: The rise in antimicrobial resistance is a global threat responsible for about 33,000 deaths in 2015 with a particular concern for extended-spectrum beta-lactamase-producing Enterobacterales (ESBL-E) and has led to a major increase in the use of carbapenems, last-resort antibiotics. METHO...
Autores principales: | Cariou, Erwann, Griffier, Romain, Orieux, Arthur, Silva, Stein, Faguer, Stanislas, Seguin, Thierry, Nseir, Saad, Canet, Emmanuel, Desclaux, Arnaud, Souweine, Bertrand, Klouche, Kada, Guisset, Olivier, Pillot, Jerome, Picard, Walter, Saghi, Tahar, Delobel, Pierre, Gruson, Didier, Prevel, Renaud, Boyer, Alexandre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10036246/ https://www.ncbi.nlm.nih.gov/pubmed/36959425 http://dx.doi.org/10.1186/s13613-023-01106-z |
Ejemplares similares
-
1452. Is Carbapenem-Sparing Therapy as Effective as Carbapenems Against Extended-Spectrum β-Lactamase Producing Enterobacteriaceae in UTI?
por: Hyun, Jonghoon, et al.
Publicado: (2019) -
Optimized β-Lactam Therapy Improves Survival in Carbapenem Non-Susceptible Gram-Negative Infections
por: Flynt, Lauren K, et al.
Publicado: (2017) -
In Vitro and In Vivo Evaluations of β-Lactam/β-Lactamase Mono- and Combined Therapies against Carbapenem-Nonsusceptible Enterobacteriaceae in Taiwan
por: Yang, Tsung-Ying, et al.
Publicado: (2020) -
Evaluating the Efficacies of Carbapenem/β-Lactamase Inhibitors Against Carbapenem-Resistant Gram-Negative Bacteria in vitro and in vivo
por: El Hafi, Bassam, et al.
Publicado: (2019) -
Predictive factors for severe long-term chronic kidney disease after acute kidney injury requiring renal replacement therapy in critically ill patients: an ancillary study of the ELVIS randomized controlled trial
por: Soum, Edouard, et al.
Publicado: (2022)